Celldex Therapeutics buy Stifel Nicolaus
Start price
26.02.26
/
50%
€26.00
Target price
26.02.27
€57.53
Performance (%)
10.85%
Price
08.05.26
€27.98
Summary
This prediction is currently active. The BUY prediction by Stifel_Nicolaus currently has a performance of 10.85%. This prediction currently runs until 26.02.27. The prediction end date can be changed by Stifel_Nicolaus at any time. Stifel_Nicolaus has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Celldex Therapeutics | 3.057% | 3.057% |
| iShares Core DAX® | 0.224% | 1.487% |
| iShares Nasdaq 100 | 6.047% | 16.188% |
| iShares Nikkei 225® | 5.724% | 11.690% |
| iShares S&P 500 | 2.172% | 8.056% |
Comments by Stifel_Nicolaus for this prediction
In the thread Celldex Therapeutics diskutieren
Celldex Therapeutics (CLDX) had its "buy" rating reaffirmed by Stifel Nicolaus. They now have a $68.00 price target on the stock, up from $58.00.
Ratings data for CLDX provided by MarketBeat
Stopped prediction by Stifel_Nicolaus for Celldex Therapeutics
Celldex Therapeutics
Start price
Target price
Perf. (%)
€33.20
18.06.24
18.06.24
€54.03
18.06.25
18.06.25
-45.18%
19.06.25
19.06.25
